CRX.L Regulatory News (CRX)

17 Nov 2006 07:00

Cyprotex PLC17 November 2006 Press Release 17 November 2006 Cyprotex PLC ("Cyprotex" or "the Company") Cyprotex PLC (AIM:CRX), the drug discovery technology and information company,today announces that Mr Robert Morrisson Atwater, the Chief Executive Officer ofthe Company, bought on Thursday 16 November 2006, 300,000 ordinary shares of0.1p each in the capital of the Company at an average price of 5.07p per share. As a consequence of this purchase, Mr Atwater's interest in the share capital ofthe Company has increased to 1,240,000 ordinary shares representing 0.94% of theissued share capital. - Ends - For further information: Cyprotex PLCRobert Morrisson Atwater Tel: +44 (0) 1625 505100Chairman & Chief Executive Officeriir@cyprotex.com www.cyprotex.com Media enquiries:Abchurch CommunicationsHeather Salmond Tel + 44 (0) 20 7398 7700Heather Salmond@abchurch-group.com www.abchurch-group.com This information is provided by RNS The company news service from the London Stock Exchange